| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | metalloendopeptidase activity | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 1.45e-08 | 120 | 74 | 8 | GO:0004222 |
| GeneOntologyMolecularFunction | metallopeptidase activity | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 7.54e-07 | 200 | 74 | 8 | GO:0008237 |
| GeneOntologyMolecularFunction | endopeptidase activity | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 CAPN15 | 2.94e-05 | 430 | 74 | 9 | GO:0004175 |
| GeneOntologyMolecularFunction | peptidase activity | TINAGL1 ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 CAPN15 | 1.44e-04 | 654 | 74 | 10 | GO:0008233 |
| GeneOntologyMolecularFunction | integrin binding | 4.83e-04 | 175 | 74 | 5 | GO:0005178 | |
| GeneOntologyMolecularFunction | extracellular matrix structural constituent | 6.68e-04 | 188 | 74 | 5 | GO:0005201 | |
| GeneOntologyBiologicalProcess | platelet activation | 1.59e-06 | 158 | 74 | 7 | GO:0030168 | |
| GeneOntologyBiologicalProcess | regulation of platelet activation | 3.91e-06 | 66 | 74 | 5 | GO:0010543 | |
| GeneOntologyBiologicalProcess | positive regulation of platelet activation | 1.57e-05 | 14 | 74 | 3 | GO:0010572 | |
| GeneOntologyBiologicalProcess | blood coagulation | 4.09e-05 | 260 | 74 | 7 | GO:0007596 | |
| GeneOntologyBiologicalProcess | coagulation | 4.72e-05 | 266 | 74 | 7 | GO:0050817 | |
| GeneOntologyBiologicalProcess | hemostasis | 4.95e-05 | 268 | 74 | 7 | GO:0007599 | |
| GeneOntologyBiologicalProcess | extracellular matrix organization | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 LAMA2 LAMB2 SEMA5A ADAMTS13 | 6.09e-05 | 377 | 74 | 8 | GO:0030198 |
| GeneOntologyBiologicalProcess | extracellular structure organization | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 LAMA2 LAMB2 SEMA5A ADAMTS13 | 6.20e-05 | 378 | 74 | 8 | GO:0043062 |
| GeneOntologyBiologicalProcess | external encapsulating structure organization | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 LAMA2 LAMB2 SEMA5A ADAMTS13 | 6.32e-05 | 379 | 74 | 8 | GO:0045229 |
| GeneOntologyBiologicalProcess | regulation of complement activation | 1.22e-04 | 27 | 74 | 3 | GO:0030449 | |
| GeneOntologyBiologicalProcess | regulation of complement activation, alternative pathway | 2.64e-04 | 7 | 74 | 2 | GO:0030451 | |
| GeneOntologyBiologicalProcess | negative regulation of complement activation, classical pathway | 3.51e-04 | 8 | 74 | 2 | GO:0045959 | |
| GeneOntologyCellularComponent | extracellular matrix | TINAGL1 ADAMTS10 PDGFB ADAMTS2 ADAMTS6 ADAMTS9 OTOGL LAMA2 LAMB2 MUC5B ADAMTS13 BMPER SSPOP SVEP1 | 6.27e-08 | 656 | 74 | 14 | GO:0031012 |
| GeneOntologyCellularComponent | external encapsulating structure | TINAGL1 ADAMTS10 PDGFB ADAMTS2 ADAMTS6 ADAMTS9 OTOGL LAMA2 LAMB2 MUC5B ADAMTS13 BMPER SSPOP SVEP1 | 6.51e-08 | 658 | 74 | 14 | GO:0030312 |
| GeneOntologyCellularComponent | collagen-containing extracellular matrix | TINAGL1 ADAMTS10 PDGFB ADAMTS2 ADAMTS9 LAMA2 LAMB2 BMPER SSPOP | 1.03e-04 | 530 | 74 | 9 | GO:0062023 |
| GeneOntologyCellularComponent | synaptic cleft | 2.15e-04 | 33 | 74 | 3 | GO:0043083 | |
| GeneOntologyCellularComponent | cell surface | SELP CFH TPO CSF3R PDGFB ADAMTS9 ADAM20 DLK1 ADAMTS13 VWDE ADAM28 CD163 | 4.96e-04 | 1111 | 74 | 12 | GO:0009986 |
| GeneOntologyCellularComponent | sex chromosome | 5.08e-04 | 44 | 74 | 3 | GO:0000803 | |
| GeneOntologyCellularComponent | protein complex involved in cell-matrix adhesion | 1.62e-03 | 17 | 74 | 2 | GO:0098637 | |
| Domain | EGF_2 | SELP TPO ATRN NELL2 ADAM20 ATRNL1 LAMA2 LAMB2 ADAM33 DLK1 VWCE SSPOP VWDE ADAM28 SVEP1 CRB2 EPHA3 PEAR1 | 4.83e-18 | 265 | 71 | 18 | PS01186 |
| Domain | EGF_1 | SELP TPO ATRN NELL2 ADAM20 ATRNL1 LAMA2 LAMB2 ADAM33 DLK1 VWCE SSPOP VWDE ADAM28 SVEP1 CRB2 PEAR1 | 6.26e-17 | 255 | 71 | 17 | PS00022 |
| Domain | EGF-like_dom | SELP TPO ATRN NELL2 ADAM20 ATRNL1 LAMA2 LAMB2 ADAM33 DLK1 VWCE VWDE ADAM28 SVEP1 CRB2 PEAR1 | 1.02e-15 | 249 | 71 | 16 | IPR000742 |
| Domain | EGF-like_CS | SELP TPO ATRN NELL2 ADAM20 ATRNL1 LAMA2 LAMB2 ADAM33 DLK1 VWCE VWDE ADAM28 SVEP1 CRB2 PEAR1 | 2.15e-15 | 261 | 71 | 16 | IPR013032 |
| Domain | EGF_3 | SELP TPO ATRN NELL2 ADAM20 ATRNL1 ADAM33 DLK1 VWCE SSPOP VWDE ADAM28 SVEP1 CRB2 PEAR1 | 9.81e-15 | 235 | 71 | 15 | PS50026 |
| Domain | EGF | SELP TPO ATRN NELL2 ATRNL1 LAMA2 LAMB2 ADAM33 DLK1 VWCE VWDE ADAM28 SVEP1 CRB2 PEAR1 | 9.81e-15 | 235 | 71 | 15 | SM00181 |
| Domain | DISINTEGRIN_1 | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 2.03e-12 | 40 | 71 | 8 | PS00427 |
| Domain | Reprolysin | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 2.03e-12 | 40 | 71 | 8 | PF01421 |
| Domain | ADAM_MEPRO | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 2.03e-12 | 40 | 71 | 8 | PS50215 |
| Domain | DISINTEGRIN_2 | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 2.03e-12 | 40 | 71 | 8 | PS50214 |
| Domain | Peptidase_M12B | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 2.03e-12 | 40 | 71 | 8 | IPR001590 |
| Domain | Disintegrin_dom | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 2.51e-12 | 41 | 71 | 8 | IPR001762 |
| Domain | TSP_1 | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADGRB3 SEMA5A ADAMTS13 SSPOP | 9.53e-11 | 63 | 71 | 8 | PF00090 |
| Domain | Peptidase_M12B_N | 1.18e-10 | 39 | 71 | 7 | IPR002870 | |
| Domain | Pep_M12B_propep | 1.18e-10 | 39 | 71 | 7 | PF01562 | |
| Domain | TSP1 | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADGRB3 SEMA5A ADAMTS13 SSPOP | 1.23e-10 | 65 | 71 | 8 | SM00209 |
| Domain | TSP1_rpt | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADGRB3 SEMA5A ADAMTS13 SSPOP | 1.23e-10 | 65 | 71 | 8 | IPR000884 |
| Domain | TSP1 | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADGRB3 SEMA5A ADAMTS13 SSPOP | 1.23e-10 | 65 | 71 | 8 | PS50092 |
| Domain | MetalloPept_cat_dom | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 7.49e-10 | 81 | 71 | 8 | IPR024079 |
| Domain | - | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 7.49e-10 | 81 | 71 | 8 | 3.40.390.10 |
| Domain | ZINC_PROTEASE | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 3.48e-09 | 98 | 71 | 8 | PS00142 |
| Domain | Peptidase_M12B_ADAM-TS | 2.76e-08 | 24 | 71 | 5 | IPR013273 | |
| Domain | Sushi | 4.31e-08 | 52 | 71 | 6 | PF00084 | |
| Domain | CUB | 4.85e-08 | 53 | 71 | 6 | PS01180 | |
| Domain | CCP | 5.44e-08 | 54 | 71 | 6 | SM00032 | |
| Domain | SUSHI | 6.80e-08 | 56 | 71 | 6 | PS50923 | |
| Domain | Sushi_SCR_CCP_dom | 7.58e-08 | 57 | 71 | 6 | IPR000436 | |
| Domain | CUB_dom | 7.58e-08 | 57 | 71 | 6 | IPR000859 | |
| Domain | EGF_extracell | 1.04e-07 | 60 | 71 | 6 | IPR013111 | |
| Domain | EGF_2 | 1.04e-07 | 60 | 71 | 6 | PF07974 | |
| Domain | EGF_Lam | 2.04e-07 | 35 | 71 | 5 | SM00180 | |
| Domain | VWFC_1 | 2.37e-07 | 36 | 71 | 5 | PS01208 | |
| Domain | VWC | 3.13e-07 | 38 | 71 | 5 | SM00214 | |
| Domain | VWFC_2 | 3.13e-07 | 38 | 71 | 5 | PS50184 | |
| Domain | Laminin_EGF | 3.13e-07 | 38 | 71 | 5 | IPR002049 | |
| Domain | VWD | 3.37e-07 | 16 | 71 | 4 | SM00216 | |
| Domain | VWF_type-D | 3.37e-07 | 16 | 71 | 4 | IPR001846 | |
| Domain | VWFD | 3.37e-07 | 16 | 71 | 4 | PS51233 | |
| Domain | VWD | 3.37e-07 | 16 | 71 | 4 | PF00094 | |
| Domain | VWF_dom | 5.25e-07 | 42 | 71 | 5 | IPR001007 | |
| Domain | Pept_M10_metallopeptidase | 5.92e-07 | 43 | 71 | 5 | IPR001818 | |
| Domain | VWC_out | 7.12e-07 | 19 | 71 | 4 | SM00215 | |
| Domain | ADAM_spacer1 | 1.61e-06 | 23 | 71 | 4 | IPR010294 | |
| Domain | ADAM_spacer1 | 1.61e-06 | 23 | 71 | 4 | PF05986 | |
| Domain | - | 1.62e-06 | 95 | 71 | 6 | 2.60.120.200 | |
| Domain | ASX_HYDROXYL | 2.19e-06 | 100 | 71 | 6 | PS00010 | |
| Domain | EGF-type_Asp/Asn_hydroxyl_site | 3.08e-06 | 106 | 71 | 6 | IPR000152 | |
| Domain | ACR | 3.15e-06 | 27 | 71 | 4 | SM00608 | |
| Domain | ADAM_Cys-rich | 3.15e-06 | 27 | 71 | 4 | IPR006586 | |
| Domain | VWC | 3.66e-06 | 28 | 71 | 4 | PF00093 | |
| Domain | EGF_LAM_2 | 4.88e-06 | 30 | 71 | 4 | PS50027 | |
| Domain | EGF_LAM_1 | 4.88e-06 | 30 | 71 | 4 | PS01248 | |
| Domain | EGF_CA | 6.95e-06 | 122 | 71 | 6 | SM00179 | |
| Domain | EGF-like_Ca-bd_dom | 7.63e-06 | 124 | 71 | 6 | IPR001881 | |
| Domain | Laminin_EGF | 9.18e-06 | 35 | 71 | 4 | PF00053 | |
| Domain | TIL | 1.13e-05 | 12 | 71 | 3 | PF01826 | |
| Domain | C8 | 1.13e-05 | 12 | 71 | 3 | PF08742 | |
| Domain | Unchr_dom_Cys-rich | 1.47e-05 | 13 | 71 | 3 | IPR014853 | |
| Domain | C8 | 1.47e-05 | 13 | 71 | 3 | SM00832 | |
| Domain | CYSTEINE_SWITCH | 1.75e-05 | 41 | 71 | 4 | PS00546 | |
| Domain | TIL_dom | 1.86e-05 | 14 | 71 | 3 | IPR002919 | |
| Domain | Growth_fac_rcpt_ | 2.82e-05 | 156 | 71 | 6 | IPR009030 | |
| Domain | Disintegrin_CS | 2.85e-05 | 16 | 71 | 3 | IPR018358 | |
| Domain | Galactose-bd-like | 2.91e-05 | 94 | 71 | 5 | IPR008979 | |
| Domain | EGF_Ca-bd_CS | 3.38e-05 | 97 | 71 | 5 | IPR018097 | |
| Domain | CUB | 3.57e-05 | 49 | 71 | 4 | PF00431 | |
| Domain | EGF_CA | 3.73e-05 | 99 | 71 | 5 | PS01187 | |
| Domain | CUB | 3.87e-05 | 50 | 71 | 4 | SM00042 | |
| Domain | ADAM_CR | 4.12e-05 | 18 | 71 | 3 | PF08516 | |
| Domain | - | 4.52e-05 | 52 | 71 | 4 | 2.60.120.290 | |
| Domain | PLAC | 4.88e-05 | 19 | 71 | 3 | PS50900 | |
| Domain | PLAC | 4.88e-05 | 19 | 71 | 3 | IPR010909 | |
| Domain | - | 5.73e-05 | 20 | 71 | 3 | 4.10.70.10 | |
| Domain | Disintegrin | 6.67e-05 | 21 | 71 | 3 | PF00200 | |
| Domain | DISIN | 6.67e-05 | 21 | 71 | 3 | SM00050 | |
| Domain | EGF | 1.18e-04 | 126 | 71 | 5 | PF00008 | |
| Domain | - | 1.71e-04 | 73 | 71 | 4 | 2.60.120.260 | |
| Domain | ConA-like_dom | 1.84e-04 | 219 | 71 | 6 | IPR013320 | |
| Domain | PSI | 2.41e-04 | 32 | 71 | 3 | PF01437 | |
| Domain | Plexin_repeat | 2.41e-04 | 32 | 71 | 3 | IPR002165 | |
| Domain | EGF_CA | 3.22e-04 | 86 | 71 | 4 | PF07645 | |
| Domain | Laminin_G_2 | 4.70e-04 | 40 | 71 | 3 | PF02210 | |
| Domain | PSI | 6.23e-04 | 44 | 71 | 3 | IPR016201 | |
| Domain | LamG | 6.23e-04 | 44 | 71 | 3 | SM00282 | |
| Domain | PSI | 7.11e-04 | 46 | 71 | 3 | SM00423 | |
| Domain | Ephrin_rec_like | 7.66e-04 | 11 | 71 | 2 | PF07699 | |
| Domain | - | 8.05e-04 | 48 | 71 | 3 | 2.120.10.80 | |
| Domain | Kelch-typ_b-propeller | 1.20e-03 | 55 | 71 | 3 | IPR015915 | |
| Domain | PLAC | 1.26e-03 | 14 | 71 | 2 | PF08686 | |
| Domain | Laminin_G | 1.40e-03 | 58 | 71 | 3 | IPR001791 | |
| Domain | Laminin_N | 1.65e-03 | 16 | 71 | 2 | IPR008211 | |
| Domain | LAMININ_NTER | 1.65e-03 | 16 | 71 | 2 | PS51117 | |
| Domain | Laminin_N | 1.65e-03 | 16 | 71 | 2 | PF00055 | |
| Domain | LamNT | 1.65e-03 | 16 | 71 | 2 | SM00136 | |
| Domain | EMI | 1.87e-03 | 17 | 71 | 2 | PS51041 | |
| Domain | CTCK_1 | 2.10e-03 | 18 | 71 | 2 | PS01185 | |
| Domain | Znf_FYVE_PHD | 2.38e-03 | 147 | 71 | 4 | IPR011011 | |
| Domain | Kelch_1 | 2.40e-03 | 70 | 71 | 3 | PF01344 | |
| Domain | Kelch_1 | 2.40e-03 | 70 | 71 | 3 | IPR006652 | |
| Domain | zf-RanBP | 3.13e-03 | 22 | 71 | 2 | PF00641 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.29e-10 | 39 | 55 | 7 | M27417 | |
| Pathway | REACTOME_O_GLYCOSYLATION_OF_TSR_DOMAIN_CONTAINING_PROTEINS | 1.29e-10 | 39 | 55 | 7 | MM15165 | |
| Pathway | REACTOME_DISEASES_ASSOCIATED_WITH_O_GLYCOSYLATION_OF_PROTEINS | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 SEMA5A MUC5B ADAMTS13 SSPOP | 1.95e-10 | 68 | 55 | 8 | M27303 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 SEMA5A MUC5B ADAMTS13 SSPOP | 8.87e-09 | 109 | 55 | 8 | MM15164 |
| Pathway | REACTOME_O_LINKED_GLYCOSYLATION | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 SEMA5A MUC5B ADAMTS13 SSPOP | 1.03e-08 | 111 | 55 | 8 | M27416 |
| Pathway | REACTOME_DISEASES_OF_GLYCOSYLATION | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 SEMA5A MUC5B ADAMTS13 SSPOP | 7.50e-08 | 143 | 55 | 8 | M27275 |
| Pathway | REACTOME_DISEASES_OF_METABOLISM | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 SEMA5A MUC5B ADAMTS13 SSPOP | 5.18e-06 | 250 | 55 | 8 | M27554 |
| Pubmed | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADGRB3 SEMA5A ADAMTS13 SSPOP | 4.28e-12 | 75 | 74 | 8 | 20637190 | |
| Pubmed | 9.50e-12 | 10 | 74 | 5 | 11167130 | ||
| Pubmed | Insights on ADAMTS proteases and ADAMTS-like proteins from mammalian genetics. | 9.22e-09 | 12 | 74 | 4 | 25770910 | |
| Pubmed | 2.63e-07 | 64 | 74 | 5 | 22261194 | ||
| Pubmed | Extracellular matrix secretion by cardiac fibroblasts: role of microRNA-29b and microRNA-30c. | 1.03e-06 | 248 | 74 | 7 | 24006456 | |
| Pubmed | ADAMTS-10 and -6 differentially regulate cell-cell junctions and focal adhesions. | 4.47e-06 | 2 | 74 | 2 | 27779234 | |
| Pubmed | 4.47e-06 | 2 | 74 | 2 | 18064672 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 37164546 | ||
| Pubmed | FUS driven circCNOT6L biogenesis in mouse and human spermatozoa supports zygote development. | 1.34e-05 | 3 | 74 | 2 | 34936029 | |
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17597069 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 29077161 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 17426950 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 31409673 | ||
| Pubmed | 1.34e-05 | 3 | 74 | 2 | 25453333 | ||
| Pubmed | The ADAMTS (A Disintegrin and Metalloproteinase with Thrombospondin motifs) family. | 1.34e-05 | 3 | 74 | 2 | 26025392 | |
| Pubmed | CFH ATRN NELL2 UBE2O TCOF1 ADAMTS9 ATRNL1 ENC1 ADGRB3 WDFY3 EXOC7 NSUN2 | 1.62e-05 | 1285 | 74 | 12 | 35914814 | |
| Pubmed | 1.65e-05 | 71 | 74 | 4 | 33541421 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 18765673 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 2099832 | ||
| Pubmed | 2.67e-05 | 4 | 74 | 2 | 22205175 | ||
| Pubmed | A neurogenomics approach to gene expression analysis in the developing brain. | 3.23e-05 | 170 | 74 | 5 | 15582152 | |
| Pubmed | 4.20e-05 | 90 | 74 | 4 | 32857879 | ||
| Pubmed | Properly formed but improperly localized synaptic specializations in the absence of laminin alpha4. | 4.45e-05 | 5 | 74 | 2 | 11369940 | |
| Pubmed | Genetic and phenotypic studies of the dark-like mutant mouse. | 4.45e-05 | 5 | 74 | 2 | 18821597 | |
| Pubmed | NELL2-mediated lumicrine signaling through OVCH2 is required for male fertility. | 4.45e-05 | 5 | 74 | 2 | 32499443 | |
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 1678389 | ||
| Pubmed | Structural elucidation of full-length nidogen and the laminin-nidogen complex in solution. | 6.66e-05 | 6 | 74 | 2 | 23948589 | |
| Pubmed | A synaptic nidogen: developmental regulation and role of nidogen-2 at the neuromuscular junction. | 6.66e-05 | 6 | 74 | 2 | 18817539 | |
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 2119632 | ||
| Pubmed | 6.66e-05 | 6 | 74 | 2 | 26555376 | ||
| Pubmed | Effect of basement membrane entactin on epidermal cell attachment and growth. | 6.66e-05 | 6 | 74 | 2 | 3794389 | |
| Pubmed | Laminin-nidogen complex. Extraction with chelating agents and structural characterization. | 6.66e-05 | 6 | 74 | 2 | 3109910 | |
| Pubmed | 7.67e-05 | 105 | 74 | 4 | 9628581 | ||
| Pubmed | 7.85e-05 | 205 | 74 | 5 | 20436479 | ||
| Pubmed | The mouse mahogany locus encodes a transmembrane form of human attractin. | 9.31e-05 | 7 | 74 | 2 | 10086356 | |
| Pubmed | Laminins promote the locomotion of skeletal myoblasts via the alpha 7 integrin receptor. | 9.31e-05 | 7 | 74 | 2 | 9004048 | |
| Pubmed | 9.31e-05 | 7 | 74 | 2 | 14557481 | ||
| Pubmed | Linkage of genes for laminin B1 and B2 subunits on chromosome 1 in mouse. | 1.24e-04 | 8 | 74 | 2 | 2993224 | |
| Pubmed | The extracellular-matrix protein matrilin 2 participates in peripheral nerve regeneration. | 1.59e-04 | 9 | 74 | 2 | 19295126 | |
| Pubmed | Identification of potentially damaging amino acid substitutions leading to human male infertility. | 1.59e-04 | 9 | 74 | 2 | 19369647 | |
| Pubmed | 1.99e-04 | 10 | 74 | 2 | 9034910 | ||
| Pubmed | A Human Tyrosine Phosphatase Interactome Mapped by Proteomic Profiling. | 2.21e-04 | 974 | 74 | 9 | 28675297 | |
| Pubmed | 2.25e-04 | 257 | 74 | 5 | 16335952 | ||
| Pubmed | SVEP1 is an endogenous ligand for the orphan receptor PEAR1. | 2.43e-04 | 11 | 74 | 2 | 36792666 | |
| Pubmed | Regional differences in the expression of laminin isoforms during mouse neural tube development. | 2.43e-04 | 11 | 74 | 2 | 21524702 | |
| Pubmed | Mutations in LAMB1 cause cobblestone brain malformation without muscular or ocular abnormalities. | 2.43e-04 | 11 | 74 | 2 | 23472759 | |
| Pubmed | 2.91e-04 | 12 | 74 | 2 | 26794322 | ||
| Pubmed | 2.91e-04 | 12 | 74 | 2 | 9396756 | ||
| Pubmed | 3.43e-04 | 13 | 74 | 2 | 36350252 | ||
| Pubmed | 4.00e-04 | 14 | 74 | 2 | 22797898 | ||
| Pubmed | 4.00e-04 | 14 | 74 | 2 | 16519819 | ||
| Pubmed | 4.54e-04 | 167 | 74 | 4 | 22159717 | ||
| Pubmed | Basement membrane composition in the early mouse embryo day 7. | 4.61e-04 | 15 | 74 | 2 | 15895400 | |
| Pubmed | Laminin alpha5 chain is required for intestinal smooth muscle development. | 4.61e-04 | 15 | 74 | 2 | 12921739 | |
| Pubmed | ADAMTS2 promotes radial migration by activating TGF-β signaling in the developing neocortex. | 4.61e-04 | 15 | 74 | 2 | 38871984 | |
| Pubmed | 4.70e-04 | 650 | 74 | 7 | 38777146 | ||
| Pubmed | 4.83e-04 | 653 | 74 | 7 | 22586326 | ||
| Pubmed | 5.26e-04 | 16 | 74 | 2 | 17601529 | ||
| Pubmed | Genetic influences on the end-stage effector phase of arthritis. | 5.26e-04 | 16 | 74 | 2 | 11489951 | |
| Pubmed | Patterns of laminins and integrins in the embryonic ventricular zone of the CNS. | 5.26e-04 | 16 | 74 | 2 | 17948866 | |
| Pubmed | 5.26e-04 | 16 | 74 | 2 | 24125951 | ||
| Pubmed | 5.42e-04 | 175 | 74 | 4 | 28071719 | ||
| Pubmed | A dual-activity topoisomerase complex regulates mRNA translation and turnover. | 5.54e-04 | 1105 | 74 | 9 | 35748872 | |
| Pubmed | The Midbrain Preisthmus: A Poorly Known Effect of the Isthmic Organizer. | 5.59e-04 | 75 | 74 | 3 | 37298722 | |
| Pubmed | 5.95e-04 | 17 | 74 | 2 | 10464288 | ||
| Pubmed | Beta1-integrins are critical for cerebellar granule cell precursor proliferation. | 5.95e-04 | 17 | 74 | 2 | 15056720 | |
| Pubmed | TGF-beta-1 up-regulates extra-cellular matrix production in mouse hepatoblasts. | 6.68e-04 | 18 | 74 | 2 | 23041440 | |
| Pubmed | Proteolysis of fibrillin-2 microfibrils is essential for normal skeletal development. | 6.68e-04 | 18 | 74 | 2 | 35503090 | |
| Pubmed | 6.68e-04 | 18 | 74 | 2 | 24025402 | ||
| Pubmed | 6.68e-04 | 18 | 74 | 2 | 24803655 | ||
| Pubmed | 6.68e-04 | 18 | 74 | 2 | 11311202 | ||
| Pubmed | 7.46e-04 | 19 | 74 | 2 | 19656773 | ||
| Pubmed | Expression analysis of the entire MMP and TIMP gene families during mouse tissue development. | 7.46e-04 | 19 | 74 | 2 | 15063736 | |
| Pubmed | 7.94e-04 | 513 | 74 | 6 | 25798074 | ||
| Pubmed | 8.28e-04 | 20 | 74 | 2 | 22911573 | ||
| Pubmed | 8.28e-04 | 20 | 74 | 2 | 21750040 | ||
| Pubmed | LMBR1L regulates lymphopoiesis through Wnt/β-catenin signaling. | 8.74e-04 | 942 | 74 | 8 | 31073040 | |
| Pubmed | Genome-wide association study of ancestry-specific TB risk in the South African Coloured population. | 9.14e-04 | 21 | 74 | 2 | 24057671 | |
| Pubmed | LRRC31 inhibits DNA repair and sensitizes breast cancer brain metastasis to radiation therapy. | 9.25e-04 | 202 | 74 | 4 | 33005030 | |
| Pubmed | 9.30e-04 | 529 | 74 | 6 | 14621295 | ||
| Pubmed | Trophoblasts regulate the placental hematopoietic niche through PDGF-B signaling. | 1.00e-03 | 22 | 74 | 2 | 22387002 | |
| Pubmed | 1.00e-03 | 22 | 74 | 2 | 12768436 | ||
| Pubmed | 1.00e-03 | 22 | 74 | 2 | 35245678 | ||
| Pubmed | 1.06e-03 | 971 | 74 | 8 | 33306668 | ||
| Pubmed | 1.10e-03 | 23 | 74 | 2 | 30814516 | ||
| Pubmed | Glycoproteomics Reveals Decorin Peptides With Anti-Myostatin Activity in Human Atrial Fibrillation. | 1.18e-03 | 97 | 74 | 3 | 27559042 | |
| Pubmed | 1.20e-03 | 24 | 74 | 2 | 29791855 | ||
| Pubmed | Dimerization quality control ensures neuronal development and survival. | 1.20e-03 | 24 | 74 | 2 | 30190310 | |
| Pubmed | 1.30e-03 | 25 | 74 | 2 | 37869988 | ||
| Pubmed | Xrcc4 physically links DNA end processing by polynucleotide kinase to DNA ligation by DNA ligase IV. | 1.30e-03 | 25 | 74 | 2 | 15385968 | |
| Pubmed | Large-scale characterization of HeLa cell nuclear phosphoproteins. | 1.30e-03 | 774 | 74 | 7 | 15302935 | |
| Pubmed | Genomic evolution of the placenta using co-option and duplication and divergence. | 1.40e-03 | 26 | 74 | 2 | 18340042 | |
| Pubmed | 1.40e-03 | 26 | 74 | 2 | 24742657 | ||
| Pubmed | 1.51e-03 | 27 | 74 | 2 | 19026994 | ||
| Pubmed | Seven new loci associated with age-related macular degeneration. | 1.75e-03 | 29 | 74 | 2 | 23455636 | |
| Pubmed | 1.75e-03 | 29 | 74 | 2 | 22613833 | ||
| Pubmed | New genetic associations detected in a host response study to hepatitis B vaccine. | 1.86e-03 | 824 | 74 | 7 | 20237496 | |
| Pubmed | 1.88e-03 | 245 | 74 | 4 | 19521500 | ||
| Pubmed | Genome-wide association study of hematological and biochemical traits in a Japanese population. | 1.97e-03 | 116 | 74 | 3 | 20139978 | |
| Pubmed | BTB-ZF factors recruit the E3 ligase cullin 3 to regulate lymphoid effector programs. | 2.00e-03 | 31 | 74 | 2 | 23086144 | |
| Interaction | EGFL7 interactions | 8.75e-06 | 77 | 73 | 5 | int:EGFL7 | |
| Interaction | DEFB135 interactions | 1.60e-05 | 42 | 73 | 4 | int:DEFB135 | |
| Interaction | ADAM2 interactions | 2.99e-05 | 17 | 73 | 3 | int:ADAM2 | |
| GeneFamily | ADAM metallopeptidases with thrombospondin type 1 motif | 2.01e-09 | 19 | 53 | 5 | 50 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 1.53e-08 | 57 | 53 | 6 | 1179 | |
| GeneFamily | ADAM metallopeptidase domain containing|CD molecules | 6.62e-05 | 27 | 53 | 3 | 47 | |
| GeneFamily | Hyalectan proteoglycans|V-set domain containing|Sushi domain containing|C-type lectin domain containing | 2.34e-04 | 41 | 53 | 3 | 1298 | |
| GeneFamily | Laminin subunits | 5.46e-04 | 12 | 53 | 2 | 626 | |
| GeneFamily | Zinc fingers RANBP2-type |RNA binding motif containing | 1.71e-03 | 21 | 53 | 2 | 89 | |
| Coexpression | NABA_MATRISOME | TINAGL1 ADAMTS10 TPO NELL2 INTS14 PDGFB ADAMTS2 ADAMTS6 ADAMTS9 OTOGL ADAM20 WFIKKN1 LAMA2 LAMB2 SEMA5A ADAM33 MUC5B ADAMTS13 BMPER VWCE SSPOP VWDE ADAM28 SVEP1 | 1.65e-16 | 1008 | 73 | 24 | MM17056 |
| Coexpression | NABA_MATRISOME | TINAGL1 ADAMTS10 TPO NELL2 INTS14 PDGFB ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 WFIKKN1 LAMA2 LAMB2 SEMA5A ADAM33 MUC5B ADAMTS13 BMPER VWCE SSPOP VWDE ADAM28 SVEP1 | 2.96e-15 | 1026 | 73 | 23 | M5889 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | TINAGL1 NELL2 INTS14 OTOGL LAMA2 LAMB2 BMPER VWCE SSPOP VWDE SVEP1 | 5.53e-12 | 191 | 73 | 11 | MM17059 |
| Coexpression | NABA_ECM_GLYCOPROTEINS | TINAGL1 NELL2 INTS14 LAMA2 LAMB2 BMPER VWCE SSPOP VWDE SVEP1 | 1.79e-10 | 196 | 73 | 10 | M3008 |
| Coexpression | NABA_CORE_MATRISOME | TINAGL1 NELL2 INTS14 OTOGL LAMA2 LAMB2 BMPER VWCE SSPOP VWDE SVEP1 | 2.29e-10 | 270 | 73 | 11 | MM17057 |
| Coexpression | NABA_CORE_MATRISOME | TINAGL1 NELL2 INTS14 LAMA2 LAMB2 BMPER VWCE SSPOP VWDE SVEP1 | 4.77e-09 | 275 | 73 | 10 | M5884 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS10 TPO PDGFB ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 WFIKKN1 SEMA5A ADAM33 MUC5B ADAMTS13 ADAM28 | 1.15e-07 | 738 | 73 | 13 | MM17058 |
| Coexpression | NABA_MATRISOME_ASSOCIATED | ADAMTS10 TPO PDGFB ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 WFIKKN1 SEMA5A ADAM33 MUC5B ADAMTS13 ADAM28 | 1.40e-07 | 751 | 73 | 13 | M5885 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 3.32e-07 | 238 | 73 | 8 | M3468 |
| Coexpression | NABA_ECM_REGULATORS | ADAMTS10 ADAMTS2 ADAMTS6 ADAMTS9 ADAM20 ADAM33 ADAMTS13 ADAM28 | 3.77e-07 | 242 | 73 | 8 | MM17062 |
| Coexpression | GAO_LARGE_INTESTINE_ADULT_CJ_IMMUNE_CELLS | CFH CSF3R ADGRB3 LAMB2 ADAM33 BMPER ARHGEF17 CSMD3 ADAM28 PEAR1 | 1.35e-06 | 505 | 73 | 10 | M39167 |
| Coexpression | DESCARTES_FETAL_LIVER_STELLATE_CELLS | 5.72e-06 | 160 | 73 | 6 | M40233 | |
| Coexpression | HAY_BONE_MARROW_STROMAL | TINAGL1 CFH ADAMTS2 ADAMTS9 OTOGL LAMB2 BMPER ARHGEF17 SVEP1 EPHA3 | 5.11e-05 | 767 | 73 | 10 | M39209 |
| Coexpression | GSE34156_TLR1_TLR2_LIGAND_VS_NOD2_AND_TLR1_TLR2_LIGAND_6H_TREATED_MONOCYTE_DN | 1.69e-04 | 185 | 73 | 5 | M8680 | |
| Coexpression | SMID_BREAST_CANCER_RELAPSE_IN_BONE_UP | 1.71e-04 | 99 | 73 | 4 | M3238 | |
| Coexpression | LEE_BMP2_TARGETS_DN | CCNE1 TMX1 CHCHD4 TCOF1 ADAMTS2 ADAMTS9 SMCHD1 ENC1 BMPER NSUN2 | 1.97e-04 | 904 | 73 | 10 | M2325 |
| Coexpression | FAN_EMBRYONIC_CTX_BRAIN_ENDOTHELIAL_2 | 2.02e-04 | 303 | 73 | 6 | M39040 | |
| Coexpression | NIKOLSKY_BREAST_CANCER_20P13_AMPLICON | 2.12e-04 | 8 | 73 | 2 | M6821 | |
| Coexpression | HE_LIM_SUN_FETAL_LUNG_C0_PERICYTE | 2.16e-04 | 195 | 73 | 5 | M45684 | |
| Coexpression | LEE_BMP2_TARGETS_DN | CCNE1 TMX1 CHCHD4 TCOF1 ADAMTS2 ADAMTS9 SMCHD1 ENC1 BMPER NSUN2 | 2.31e-04 | 922 | 73 | 10 | MM1068 |
| Coexpression | GSE3691_IFN_PRODUCING_KILLER_DC_VS_PLASMACYTOID_DC_SPLEEN_DN | 2.37e-04 | 199 | 73 | 5 | M6365 | |
| Coexpression | GSE43955_1H_VS_60H_ACT_CD4_TCELL_WITH_TGFB_IL6_DN | 2.43e-04 | 200 | 73 | 5 | M9685 | |
| Coexpression | MANNO_MIDBRAIN_NEUROTYPES_HRGL2A | 2.62e-04 | 600 | 73 | 8 | M39055 | |
| CoexpressionAtlas | placenta | 2.40e-06 | 349 | 71 | 9 | placenta | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_500 | 2.82e-06 | 356 | 71 | 9 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_500 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_top-relative-expression-ranked_1000 | CCNE1 NELL2 ADAMTS6 ADAMTS9 ATRNL1 ADGRB3 LAMA2 SEMA5A DLK1 BMPER CSMD3 SVEP1 | 5.25e-06 | 734 | 71 | 12 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_1000 |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_500 | 6.55e-06 | 395 | 71 | 9 | gudmap_developingGonad_P2_epididymis_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_top-relative-expression-ranked_1000 | CFH ZCWPW1 ADAMTS2 ADAMTS9 ATRNL1 ENC1 LAMA2 SEMA5A DLK1 NCAPG2 SVEP1 EPHA3 | 8.30e-06 | 768 | 71 | 12 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_1000 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_top-relative-expression-ranked_1000 | CFH ZCWPW1 ADAMTS2 ADAMTS9 ATRNL1 ENC1 LAMA2 SEMA5A DLK1 NCAPG2 SVEP1 EPHA3 | 8.86e-06 | 773 | 71 | 12 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_1000 | CFH SUSD4 CNOT6L ADAMTS2 ADAMTS9 ADGRB3 SEMA5A DLK1 WDFY3 FUS SVEP1 EPHA3 | 1.26e-05 | 801 | 71 | 12 | gudmap_developingGonad_e14.5_ epididymis_1000 |
| CoexpressionAtlas | Stromal Cells, St.31-38-44-.SLN, CD45- gp38- CD31- CD44-, Lymph Node, avg-2 | 1.95e-05 | 453 | 71 | 9 | GSM777067_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_1000 | CFH CNOT6L ADAMTS2 ADAMTS9 ADGRB3 SEMA5A DLK1 WDFY3 FUS SVEP1 EPHA3 | 5.89e-05 | 790 | 71 | 11 | gudmap_developingGonad_e16.5_epididymis_1000 |
| CoexpressionAtlas | ratio_EmbryoidBody_vs_StemCell_top-relative-expression-ranked_2500_k-means-cluster#3 | DCDC1 ADAMTS6 ADAMTS9 ENC1 ADGRB3 SEMA5A ADAM33 DLK1 BMPER SSPOP SVEP1 CRB2 EPHA3 | 6.01e-05 | 1094 | 71 | 13 | ratio_EB_vs_SC_2500_K3 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_500 | 6.20e-05 | 406 | 71 | 8 | gudmap_developingGonad_e16.5_epididymis_500 | |
| CoexpressionAtlas | DevelopingGonad_P2_epididymis_emap-30199_top-relative-expression-ranked_1000 | CFH SUSD4 CNOT6L ADAMTS2 ADAMTS9 LAMA2 SEMA5A DLK1 WDFY3 FUS EPHA3 | 6.37e-05 | 797 | 71 | 11 | gudmap_developingGonad_P2_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_1000 | CFH CNOT6L ADAMTS2 ADAMTS9 ADGRB3 LAMA2 SEMA5A DLK1 WDFY3 FUS EPHA3 | 6.52e-05 | 799 | 71 | 11 | gudmap_developingGonad_e18.5_epididymis_1000 |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_500 | 6.98e-05 | 413 | 71 | 8 | gudmap_developingGonad_e14.5_ epididymis_500 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitLeydig_MafB_k-means-cluster#1_top-relative-expression-ranked_1000 | 7.90e-05 | 310 | 71 | 7 | gudmap_dev gonad_e12.5_M_InterstitLeydig_MafB_k1_1000 | |
| CoexpressionAtlas | Stromal Cells, Fi.MTS15+.Th, CD45- PDGFRa+ MTS15+, Thymus, avg-3 | 1.17e-04 | 445 | 71 | 8 | GSM777043_500 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_k-means-cluster#2_top-relative-expression-ranked_100 | 1.36e-04 | 30 | 71 | 3 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100_k2 | |
| CoexpressionAtlas | DevelopingLowerUrinaryTract_P2_bladder stroma (LCM)_emap-30396_top-relative-expression-ranked_100 | 1.65e-04 | 82 | 71 | 4 | gudmap_developingLowerUrinaryTract_P2_bladder stroma (LCM)_100 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_k-means-cluster#1_top-relative-expression-ranked_500 | 1.77e-04 | 156 | 71 | 5 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_k1_500 | |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_top-relative-expression-ranked_100 | 1.98e-04 | 86 | 71 | 4 | gudmap_developingGonad_e16.5_epididymis_100 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.15e-04 | 256 | 71 | 6 | gudmap_developingGonad_e14.5_ epididymis_1000_k4 | |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_200 | 2.36e-04 | 166 | 71 | 5 | gudmap_developingGonad_e18.5_epididymis_200 | |
| CoexpressionAtlas | dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k-means-cluster#4_top-relative-expression-ranked_1000 | 2.39e-04 | 261 | 71 | 6 | gudmap_dev lower uro neuro_e15.5_PelvicGanglion_Sox10_k4_1000 | |
| CoexpressionAtlas | DevelopingGonad_e14.5_ epididymis_emap-29141_top-relative-expression-ranked_200 | 2.43e-04 | 167 | 71 | 5 | gudmap_developingGonad_e14.5_ epididymis_200 | |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | CFH ZCWPW1 ADAMTS2 ADAMTS9 ATRNL1 ENC1 LAMA2 DLK1 SVEP1 EPHA3 | 2.49e-04 | 777 | 71 | 10 | gudmap_dev gonad_e13.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k-means-cluster#2_top-relative-expression-ranked_1000 | 2.59e-04 | 265 | 71 | 6 | gudmap_dev gonad_e13.5_F_VascAssocMesenchStromOvary_MafB_k2_1000 | |
| CoexpressionAtlas | dev gonad_e12.5_M_InterstitTestis_Sma_top-relative-expression-ranked_1000 | TINAGL1 ZCWPW1 ADAMTS2 ADAMTS9 ENC1 LAMA2 SEMA5A DLK1 SVEP1 EPHA3 | 2.93e-04 | 793 | 71 | 10 | gudmap_dev gonad_e12.5_M_InterstitTestis_Sma_1000 |
| CoexpressionAtlas | AravindRamakr_EmbryoidBody-LF_top-relative-expression-ranked_2500_k-means-cluster#2 | NELL2 DCDC1 ADAMTS6 ATRNL1 SEMA5A DLK1 UPK3A BMPER SVEP1 CRB2 EPHA3 | 2.99e-04 | 951 | 71 | 11 | Arv_EB-LF_2500_K2 |
| CoexpressionAtlas | dev gonad_e13.5_M_InterstitFLeydig_MafB_k-means-cluster#4_top-relative-expression-ranked_500 | 3.61e-04 | 182 | 71 | 5 | gudmap_dev gonad_e13.5_M_InterstitFLeydig_MafB_k4_500 | |
| CoexpressionAtlas | ratio_induced-Mesoderm_vs_StemCell_top-relative-expression-ranked_1000 | CSF3R PDGFB ADAMTS9 ENC1 SEMA5A DLK1 BMPER CSMD3 SSPOP ADAM28 CD163 | 3.93e-04 | 982 | 71 | 11 | PCBC_ratio_MESO-5_vs_SC_1000 |
| CoexpressionAtlas | DevelopingGonad_e18.5_epididymis_emap-13166_top-relative-expression-ranked_500 | 4.00e-04 | 404 | 71 | 7 | gudmap_developingGonad_e18.5_epididymis_500 | |
| CoexpressionAtlas | Progenitor-Cell-Biology-Consortium_EmbryoidBody_from_inducedPluripotentialStemCells_derived from_from_fibroblast_top-relative-expression-ranked_1000 | NELL2 CSF3R ADAMTS2 ATRNL1 ENC1 SEMA5A DLK1 UPK3A SVEP1 CRB2 EPHA3 | 4.07e-04 | 986 | 71 | 11 | PCBC_EB_fibroblast_1000 |
| CoexpressionAtlas | DevelopingGonad_e16.5_epididymis_emap-29702_k-means-cluster#5_top-relative-expression-ranked_1000 | 5.18e-04 | 197 | 71 | 5 | gudmap_developingGonad_e16.5_epididymis_1000_k5 | |
| CoexpressionAtlas | Fetal Liver, SC.LTSL.FL, IgM- CD24- CD117+ IL7R- CD150+ CD48- AA4.1+ CD43+, Fetal Liver, avg-3 | 5.26e-04 | 423 | 71 | 7 | GSM791126_500 | |
| CoexpressionAtlas | Stromal Cells, Fi.Sk, gp38+ CD140a+, Skin, avg-4 | 6.38e-04 | 437 | 71 | 7 | GSM777046_500 | |
| CoexpressionAtlas | Stromal Cells, LEC.MLN, gp38+ CD31+, Lymph Node, avg-4 | 6.55e-04 | 439 | 71 | 7 | GSM777059_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.MLN, gp38- CD31+, Lymph Node, avg-5 | 8.19e-04 | 456 | 71 | 7 | GSM777032_500 | |
| CoexpressionAtlas | Stromal Cells, BEC.SLN, gp38- CD31+, Lymph Node, avg-4 | 8.51e-04 | 459 | 71 | 7 | GSM777037_500 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|human_hepatoblastoma / Sample and Cell Type and Tumor Cluster (all cells) | 9.67e-10 | 191 | 73 | 8 | 78c3c2fdb68c3407f2436f90e1e6a780bbf8b79e | |
| ToppCell | background-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 1.28e-09 | 198 | 73 | 8 | 79f32f965aed6a10c5cb803173e3db7b32e07a91 | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(ADAMDEC1+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 1.23e-08 | 169 | 73 | 7 | c0824a93674e2bff0f09b2d2fab5bab016a2e379 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D032|Children_(3_yrs) / Lineage, Cell type, age group and donor | 2.47e-08 | 187 | 73 | 7 | 86250acf088ec0c4800a0dfa031b0d4f7e52c342 | |
| ToppCell | 10x3'2.3-week_17-19-Mesenchymal_osteo-stroma-osteochondral_precursor|week_17-19 / cell types per 3 fetal stages;per 3',per 5' | 2.66e-08 | 189 | 73 | 7 | 1ff4f8da572bdc6356e9df9f41a7f62c81d4c570 | |
| ToppCell | Mesenchymal-pericyte_cell|World / Lineage, Cell type, age group and donor | 2.66e-08 | 189 | 73 | 7 | d7ed96add29f219183c802895fbff519b627f635 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 2.97e-08 | 192 | 73 | 7 | 8d56e360ebc624ca4cd7f0af4f3cc599c244f134 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 194 | 73 | 7 | bbc625b4cc53bb7d6254fde287258e51f9171572 | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 194 | 73 | 7 | fcd5e9238d299c41f0bf9693b56cd8c900d2112b | |
| ToppCell | PCW_07-8.5-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_07-8.5 / Celltypes from embryonic and fetal-stage human lung | 3.18e-08 | 194 | 73 | 7 | fb80a0271ccb1cb3f954ebcf2c5945cb6adb6b8c | |
| ToppCell | facs-Kidney-nan-18m-Mesenchymal-mesangial_cell|Kidney / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.18e-08 | 194 | 73 | 7 | 6afc21c5fec30ab8e373e3e46ab7866204c805b6 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 3.30e-08 | 195 | 73 | 7 | 77e47d2e8b3eb7f7c9620369ccaf87581f923bdb | |
| ToppCell | 5'-Adult-LargeIntestine-Mesenchymal-fibroblastic-Stromal_1_(CCL11+)|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 3.42e-08 | 196 | 73 | 7 | 2ab9735aa7a7e95dcf6b0bdf0427f7b57f6349ee | |
| ToppCell | background-Hepatic_Stellate_cells|background / Sample and Cell Type and Tumor Cluster (all cells) | 3.66e-08 | 198 | 73 | 7 | bd11b0e9e80449aab979a02c1023e0638c431c7c | |
| ToppCell | Bronchial-10x5prime-Stromal-Fibroblastic-Fibro_immune_recruiting|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 3.79e-08 | 199 | 73 | 7 | 0cdbedf09ec72734b86ddab3fec562e066afed92 | |
| ToppCell | Bronchial-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | 389cc775c8419d90fb77cd794376d2160a7bf44e | |
| ToppCell | Bronchial-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 3.92e-08 | 200 | 73 | 7 | cae972324d1dfea6efeaf6013f265c7c6bb48db4 | |
| ToppCell | facs-Diaphragm-Limb_Muscle-24m|Diaphragm / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 3.55e-07 | 169 | 73 | 6 | 12bdc709bc000d7f9061ecd9fbd57233eaacb7e2 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 3.55e-07 | 169 | 73 | 6 | a84490724a206c9bbb145f7ce08613f91d100ac4 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-myofibroblast_cell-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.07e-07 | 173 | 73 | 6 | 1f16d47f5548e257e4b17f8070c5619780a9c5fd | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-Adaptive_/_Maladaptive_/_Repairing_Fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.36e-07 | 175 | 73 | 6 | 795a6564d5a75ffd35d39f5274b9e8d28708bbc8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-airway_smooth_muscle_cell|Children_(3_yrs) / Lineage, Cell type, age group and donor | 4.66e-07 | 177 | 73 | 6 | b59967219f7d874805768e247c0eb2bc4d4420c8 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-pericyte_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 5.31e-07 | 181 | 73 | 6 | 451b87ac95154bb80018b8dd245b4a6389d81411 | |
| ToppCell | COVID-19-Heart-EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.48e-07 | 182 | 73 | 6 | e67f3234165199085c793915ebb1f9bbd845e933 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|COVID-19 / Disease (COVID-19 only), tissue and cell type | 5.48e-07 | 182 | 73 | 6 | fbd5e332df73bf7141c822fa67b76367dc962017 | |
| ToppCell | LA-07._Pericyte|World / Chamber and Cluster_Paper | 5.66e-07 | 183 | 73 | 6 | e3835db4795362b0442d5893baf2a78efcc20428 | |
| ToppCell | LV-07._Pericyte|World / Chamber and Cluster_Paper | 5.66e-07 | 183 | 73 | 6 | 273db6a3b00a93ca852498471187b642b5368185 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 5.85e-07 | 184 | 73 | 6 | e061e85c4bb19f49f6451ddd7a9077d7378ee365 | |
| ToppCell | COVID-19-Heart-Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 5.85e-07 | 184 | 73 | 6 | 21790cdfa3b4036ad413fd44b94e31563116f25f | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell-D231|Adult / Lineage, Cell type, age group and donor | 6.03e-07 | 185 | 73 | 6 | fb6bd7e849ecf4ed9cd9c4e2a946a2d12d62f804 | |
| ToppCell | LA-07._Pericyte|LA / Chamber and Cluster_Paper | 6.03e-07 | 185 | 73 | 6 | ba5baa4d7f097108622674de5b7f4fd279843d24 | |
| ToppCell | human_hepatoblastoma-Hepatic_Stellate_cells|World / Sample and Cell Type and Tumor Cluster (all cells) | 6.23e-07 | 186 | 73 | 6 | cb1fc4b9140666b43415e21c9b434dc9b144e9d0 | |
| ToppCell | primary_auditory_cortex_(A1C)-Neuronal-Glutamatergic_Excit-Glut_C-D_(RORB)|primary_auditory_cortex_(A1C) / Sample groups (6 Anatomical region groups), with 5 level hierarchy of cell types | 6.43e-07 | 187 | 73 | 6 | f18628ffc7ff7c762b8339ba8822cf0c3157f469 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-07 | 187 | 73 | 6 | 4e553721fa5598cb211f44e3226280b7e6885484 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-07 | 187 | 73 | 6 | d36e7fc6125e7a4310499365022d38f34b757a73 | |
| ToppCell | droplet-Pancreas-Exocrine-18m-Mesenchymal-pancreatic_stellate_cell|Pancreas / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 6.43e-07 | 187 | 73 | 6 | 827eae63fabf6892a82ce7779b5f395958d3d628 | |
| ToppCell | Control-Fibroblasts-Other_FB|Control / group, cell type (main and fine annotations) | 6.43e-07 | 187 | 73 | 6 | bd3739c4a52aa1ba5deffd778e113a9800f7e158 | |
| ToppCell | COVID-19-Heart-Fib_1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 6.63e-07 | 188 | 73 | 6 | fe361215f4ba841aa5e1e581fb56f2f4d3ccd201 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.05e-07 | 190 | 73 | 6 | efb757f11c2809e66ddb48a5c84f5433f111cb7c | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D088|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.05e-07 | 190 | 73 | 6 | 0fea33f2dc1efa23aaa2da1c318482a52a313ff1 | |
| ToppCell | Control-Fibroblasts|Control / group, cell type (main and fine annotations) | 7.05e-07 | 190 | 73 | 6 | 3a42a9b98d954685d38a741f44545898d0e3e9ce | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-07 | 191 | 73 | 6 | 107113b930d9ad171f1b2aa20df4567c94fae7d8 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-Myocytic_interstitial_cell-Myofibroblast|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.27e-07 | 191 | 73 | 6 | bc353a79a1d11ca52bba5e3874a80d432e1a7715 | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2-AF1|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.27e-07 | 191 | 73 | 6 | 6688cee34beee4f151ac17fccbc9c26a9aad72e1 | |
| ToppCell | PCW_10-12-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_10-12 / Celltypes from embryonic and fetal-stage human lung | 7.50e-07 | 192 | 73 | 6 | 4c9d748f209cc1e13d28c8c7f5180ab8522e0fbf | |
| ToppCell | facs-Limb_Muscle-ForelimbandHindlimb-3m-Mesenchymal-mesenchymal_stem_cell|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.50e-07 | 192 | 73 | 6 | beac6b3c191b11add8e39e8d04562b478ea8929e | |
| ToppCell | nucseq-Mesenchymal-Fibroblastic-Fibroblastic_2|nucseq / Celltype signatures by Technology, Lineage, Lineage_subclass, Celltype_group, Cell_type2 | 7.50e-07 | 192 | 73 | 6 | 99ce9e3c4c50cf64ebb62145f2b5420efa0db309 | |
| ToppCell | COVID-19-Heart-Fib_+_EC_+_Pericyte|Heart / Disease (COVID-19 only), tissue and cell type | 7.50e-07 | 192 | 73 | 6 | 60b1312e84f6d6448365a952469c506c00b5fe93 | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_2_cell|Adult / Lineage, Cell type, age group and donor | 7.50e-07 | 192 | 73 | 6 | d21f0f577156f17c899b08871046a26b88aea011 | |
| ToppCell | Mesenchymal-matrix_fibroblast_2_cell|World / Lineage, Cell type, age group and donor | 7.50e-07 | 192 | 73 | 6 | a769158c49d2b208c4224d85e7ae68c85cc372ed | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Descending_Vasa_Recta_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.50e-07 | 192 | 73 | 6 | 56b021c297a21dff357531f21e2464f85186106d | |
| ToppCell | Adult-Mesenchymal-matrix_fibroblast_1_cell-D231|Adult / Lineage, Cell type, age group and donor | 7.73e-07 | 193 | 73 | 6 | ef2f456c094e6e3c6ee81e0668c953cb8d0e1c0a | |
| ToppCell | 3'-GW_trimst-1.5-LargeIntestine-Mesenchymal-fibroblastic|GW_trimst-1.5 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 7.73e-07 | 193 | 73 | 6 | 68089ba4123e2f9bea9aae0023a844b5a57bfc0e | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_myocytic-mes_immature_ASM1_(8)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 7.73e-07 | 193 | 73 | 6 | e2b455387d1de7812305200a2041a0f4759a6f54 | |
| ToppCell | Children_(3_yrs)-Mesenchymal-matrix_fibroblast_1_cell-D139|Children_(3_yrs) / Lineage, Cell type, age group and donor | 7.96e-07 | 194 | 73 | 6 | e93de9428c986b8943fc169258847c650cfab0e5 | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_1_cell|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 7.96e-07 | 194 | 73 | 6 | 011e14d9ed1393275f892060e7708ffadcd0767f | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 194 | 73 | 6 | 415801a3dfacf05f2b603fb424df3d045190a812 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal-hepatic_stellate_cell|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 194 | 73 | 6 | 256cb33ec90328f2704921fb0fe0fd9812e138b0 | |
| ToppCell | COVID-19-Heart-Fib_2|Heart / Disease (COVID-19 only), tissue and cell type | 7.96e-07 | 194 | 73 | 6 | d91c9f2ec47319051fc398320693fddbe8bbd4d6 | |
| ToppCell | IPF-Stromal-Pericyte|World / Disease state, Lineage and Cell class | 7.96e-07 | 194 | 73 | 6 | 1a41da29d5adaf766a84eff0003b959e4523f7f1 | |
| ToppCell | droplet-Liver-LIVER-NPC-1m-Mesenchymal|Liver / Large_Intestine_Pancreas_Liver - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 7.96e-07 | 194 | 73 | 6 | 7942bc83c1bdca687795b91aa232824d603f9b09 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_progenitor|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 69a29d03e664b72f32d41876510c62345c3aed31 | |
| ToppCell | renal_cortex_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.21e-07 | 195 | 73 | 6 | 3c3703f092b6fc1b7333426fb5e2823bfb74bb57 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 1cffae2b08dbfa1c633ce24023e89b66d28b5431 | |
| ToppCell | facs-GAT-Fat-3m-Mesenchymal-mesenchymal_stem_cell_of_adipose|GAT / Fat_BAT_GAT_MAT_SCAT - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.21e-07 | 195 | 73 | 6 | 9cef6f18664518060af7c192310dddce6d70345a | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal-matrix_fibroblast_2_cell-D062|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.45e-07 | 196 | 73 | 6 | 525d6c8a277364e624e7cc586275f8a891436b57 | |
| ToppCell | PCW_05-06-Mesenchymal|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 8.45e-07 | 196 | 73 | 6 | dca52c57ba35d9395cdbca8b881f12ece721b10f | |
| ToppCell | IPF-Stromal-Pericyte|IPF / Disease state, Lineage and Cell class | 8.45e-07 | 196 | 73 | 6 | 8b6ff47ce5291d223f5e639fc45cd9267f418256 | |
| ToppCell | 3'-Parenchyma_lung-Endothelial-Blood_vessel_EC-vein_endothelial_cell-EC_venous_pulmonary-EC_venous_pulmonary_L.2.2.1.1|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 8.71e-07 | 197 | 73 | 6 | 76b61e60a757e58b465569538e632d6d9953e89a | |
| ToppCell | kidney_cells-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 8.97e-07 | 198 | 73 | 6 | 5e781583908c4ee107d986904a646a7c6b8e3591 | |
| ToppCell | Tracheal-NucSeq-Stromal-Myofibroblastic-Muscle_smooth_systemic_arterial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 8.97e-07 | 198 | 73 | 6 | 7dd874b09c81cc512ccc1e9b65f290a5f94d736e | |
| ToppCell | Fetal_29-31_weeks-Mesenchymal|Fetal_29-31_weeks / Lineage, Cell type, age group and donor | 8.97e-07 | 198 | 73 | 6 | 21cf4d81386761d09d0f6829c01c198e5524176d | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.24e-07 | 199 | 73 | 6 | dfc5c7a4a093baa7158dd8d4d29a870d9c469a3f | |
| ToppCell | Mesenchymal|World / Lineage, Cell type, age group and donor | 9.24e-07 | 199 | 73 | 6 | 4bac110c2b3609f6ee5d0e3275da0824a6240270 | |
| ToppCell | Tracheal-NucSeq-Stromal-Peri/Epineurial_|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.24e-07 | 199 | 73 | 6 | 3835452e4848d7f7dd8651c17b746b271ef39688 | |
| ToppCell | kidney_cells-Hypertensive_with+without-CKD-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 9.24e-07 | 199 | 73 | 6 | 33f1669eeb701986b4dec409efdb6c06c3c41c2b | |
| ToppCell | Smart-start-Cell-Wel_seq-Non-neoplastic-Vascular-Mural_cell-Perivascular_fibroblast-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 9.24e-07 | 199 | 73 | 6 | c1760581c34b81d1d92c67500a1c8944e9cc6dad | |
| ToppCell | Parenchyma_Control_(B.)-Stromal-TX-Smooth_muscle-1|Parenchyma_Control_(B.) / Sample group, Lineage and Cell type | 9.51e-07 | 200 | 73 | 6 | 0c648941447c738caf62f2d71e296d6cca492c8b | |
| ToppCell | 10x5'v1-week_14-16-Mesenchymal_osteo-stroma-osteochondral_precursor|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 9.51e-07 | 200 | 73 | 6 | ad3fb8ef0be45032369d1325024787fbe1dfb8d6 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte-Muscle_pericyte_pulmonary|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 8158f4eaeff945a6788c8e732b7a1b0d78052a06 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1-|Control / Location, Disease Group, Cell group, Cell class and sub_cluster (2021.03.01) | 9.51e-07 | 200 | 73 | 6 | 522a51a284d2992d519c4669e1a48c8ebcc08c80 | |
| ToppCell | Parenchymal-NucSeq-Stromal|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | cf433f9b43d7db07acaf70e060f8f77c974e72f3 | |
| ToppCell | Skin-Fibroblasts|Skin / Skin and Kidney Cells in Lupus Nephritis Patients. | 9.51e-07 | 200 | 73 | 6 | f777eadf571a1a6d246da87346a9cb9d511c2e81 | |
| ToppCell | Tracheal-10x3prime_v2-Stromal-Pericyte|10x3prime_v2 / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 600d56257b1b0cda8ed2fd0db92c6551711f7d6d | |
| ToppCell | Bronchial-10x5prime-Stromal-Pericyte|10x5prime / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 362706445edb33b313684efe50b1f44f5f816e67 | |
| ToppCell | Lung_Parenchyma-Control-Mesenchymal-Mesenchymal-Smooth_muscle-1|Control / Location, Disease Group, Cell group, Cell class (2021.03.09) | 9.51e-07 | 200 | 73 | 6 | 94f1fa61aa82eb9f411b2b1cb759476939ab5db7 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte-Muscle_pericyte_systemic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 9d3ae9ea47b1017adb63aa02d10e98193d478458 | |
| ToppCell | Tracheal-NucSeq-Stromal-Pericyte|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 78cd0b7d221ef855512ee9ac9a291f61622c2e24 | |
| ToppCell | Parenchymal-NucSeq-Stromal-Fibroblastic|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 311fab076f2ceb258e3970eb21e39344b894042a | |
| ToppCell | Tracheal-NucSeq-Stromal-Fibroblastic-Fibro_peribronchial|NucSeq / Cell types per location group and 10X technology with lineage, and cell group designations | 9.51e-07 | 200 | 73 | 6 | 58b38f9a484ee94191091a0659ed62ebed2d4a14 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-proliferative_fibroblast|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 4.08e-06 | 145 | 73 | 5 | 051d964ff6bdc12ba3f0459d3e6ab16fa9507b0b | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.02e-06 | 157 | 73 | 5 | f147e24f2ece82e1c54750868954d09b3c461804 | |
| ToppCell | Adult-Mesenchymal-myofibroblast_cell-D122|Adult / Lineage, Cell type, age group and donor | 6.21e-06 | 158 | 73 | 5 | 410fa08c9d880d27e80ec939fa5ba5a41dcb31ab | |
| ToppCell | Children_(3_yrs)-Mesenchymal-chondrocyte-D046|Children_(3_yrs) / Lineage, Cell type, age group and donor | 6.21e-06 | 158 | 73 | 5 | e5636c0b608d68bd426a2b446ac508e4512e86a4 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Mesenchymal-glomerular_mesenchymal_cell-Mesangial_Cell-mesangial_typical|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 6.80e-06 | 161 | 73 | 5 | 1b805f77790aeb8a71b08bfac2fe2eed7343258f | |
| ToppCell | facs-Lung-24m-Endothelial-capillary_endothelial-capillary_endothelial_cell-capillary_type_1_endothelial_cell|24m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 7.01e-06 | 162 | 73 | 5 | bf886e22ff2a20353499004b53f25fb9e6574896 | |
| ToppCell | renal_medulla_nuclei-Renal_AKI_(acute_kidney_injury)-Endothelial-blood_vessel_endothelial_cell_of_kidney-arteriolar_vasa-recta_endothelial-Afferent_/_Efferent_Arteriole_Endothelial_Cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.89e-06 | 166 | 73 | 5 | 8e5f2afbeffae5e77fcb29e8fe9f5aa49779b619 | |
| ToppCell | Adult-Epithelial-lung_goblet_cell-D122|Adult / Lineage, Cell type, age group and donor | 8.13e-06 | 167 | 73 | 5 | 6efbb2ef6adc8da5dd67210969f825f5cc8ed022 | |
| ToppCell | TCGA-Stomach-Primary_Tumor-Stomach_Adenocarcinoma-Stomach_Adenocarcinoma_-_Diffuse-3|TCGA-Stomach / Sample_Type by Project: Shred V9 | 8.13e-06 | 167 | 73 | 5 | d2230c894ccf9dbba9196e079ae81f384d43da63 | |
| ToppCell | renal_medulla_nuclei-Hypertensive_with+without-CKD-Mesenchymal-Fibroblast-kidney_interstitial_fibroblast-kidney_interstitial_fibroblast_5|Hypertensive_with+without-CKD / Celltypes from Cells and Nuclei per compartment and clinical group | 8.37e-06 | 168 | 73 | 5 | d19a115365c5415e51c039718d7669de788fcf33 | |
| Drug | Protriptyline hydrochloride [1225-55-4]; Down 200; 13.4uM; MCF7; HT_HG-U133A | 2.42e-07 | 196 | 74 | 8 | 5438_DN | |
| Drug | Cefadroxil [50370-12-2]; Up 200; 11uM; HL60; HT_HG-U133A | 3.48e-06 | 196 | 74 | 7 | 1323_UP | |
| Drug | CP-944629 [668990-94-1]; Up 200; 10uM; PC3; HT_HG-U133A | 3.48e-06 | 196 | 74 | 7 | 7502_UP | |
| Drug | Metaproterenol sulfate, orciprenaline sulfate [5874-97-5]; Down 200; 7.6uM; MCF7; HT_HG-U133A | 3.60e-06 | 197 | 74 | 7 | 2845_DN | |
| Drug | Sulfapyridine [144-83-2]; Up 200; 16uM; PC3; HT_HG-U133A | 3.72e-06 | 198 | 74 | 7 | 7151_UP | |
| Drug | Cyclobenzaprine hydrochloride [6202-23-9]; Up 200; 12.8uM; HL60; HT_HG-U133A | 3.83e-05 | 192 | 74 | 6 | 1332_UP | |
| Drug | Apomorphine hydrochloride hemihydrate [41372-20-7]; Up 200; 6.4uM; PC3; HG-U133A | 4.29e-05 | 196 | 74 | 6 | 1923_UP | |
| Drug | Tiratricol, 3,3',5-triiodothyroacetic acid [51-24-1]; Down 200; 6.4uM; MCF7; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 2259_DN | |
| Drug | Ketoprofen [22071-15-4]; Down 200; 15.8uM; MCF7; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 4751_DN | |
| Drug | Baclofen (R,S) [1134-47-0]; Down 200; 18.8uM; PC3; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 6313_DN | |
| Drug | Sulfacetamide sodic hydrate [6209-17-2]; Up 200; 15.8uM; MCF7; HT_HG-U133A | 4.42e-05 | 197 | 74 | 6 | 1695_UP | |
| Drug | Diclofenac sodium [15307-79-6]; Up 200; 12.6uM; MCF7; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 2756_UP | |
| Drug | Nitrendipine [39562-70-4]; Down 200; 11uM; PC3; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 6304_DN | |
| Drug | Heptaminol hydrochloride [543-15-7]; Up 200; 22uM; PC3; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 7313_UP | |
| Drug | (1)-Nipecotic acid [498-95-3]; Up 200; 31uM; PC3; HT_HG-U133A | 4.54e-05 | 198 | 74 | 6 | 7296_UP | |
| Drug | Carbarsone [121-59-5]; Up 200; 15.4uM; HL60; HT_HG-U133A | 4.67e-05 | 199 | 74 | 6 | 1313_UP | |
| Drug | Acenocoumarol [152-72-7]; Up 200; 11.4uM; PC3; HT_HG-U133A | 4.81e-05 | 200 | 74 | 6 | 2077_UP | |
| Disease | atypical hemolytic-uremic syndrome (is_marker_for) | 1.76e-05 | 3 | 72 | 2 | DOID:0080301 (is_marker_for) | |
| Disease | Sushi, von Willebrand factor type A, EGF and pentraxin domain-containing protein 1 measurement | 3.51e-05 | 4 | 72 | 2 | EFO_0803113 | |
| Disease | protein delta homolog 1 measurement | 5.84e-05 | 5 | 72 | 2 | EFO_0801938 | |
| Disease | scoliosis (implicated_via_orthology) | 5.84e-05 | 5 | 72 | 2 | DOID:0060249 (implicated_via_orthology) | |
| Disease | Stage IV Skin Melanoma | 1.22e-04 | 7 | 72 | 2 | C1321872 | |
| Disease | sodium measurement, diastolic blood pressure | 1.22e-04 | 7 | 72 | 2 | EFO_0006336, EFO_0009282 | |
| Disease | tumor necrosis factor receptor superfamily member 19L measurement | 1.63e-04 | 8 | 72 | 2 | EFO_0008309 | |
| Disease | T-cell surface glycoprotein CD3 epsilon chain measurement | 4.50e-04 | 13 | 72 | 2 | EFO_0802114 | |
| Disease | sinusitis (is_marker_for) | 8.76e-04 | 18 | 72 | 2 | DOID:0050127 (is_marker_for) | |
| Disease | S-6-hydroxywarfarin to S-warfarin ratio measurement | 1.32e-03 | 88 | 72 | 3 | EFO_0803332 | |
| Disease | Liver carcinoma | 1.50e-03 | 507 | 72 | 6 | C2239176 | |
| Disease | L lactate dehydrogenase measurement | 1.84e-03 | 26 | 72 | 2 | EFO_0004808 | |
| Disease | platelet component distribution width | 2.44e-03 | 755 | 72 | 7 | EFO_0007984 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| LQQGDPCWVCGSLPV | 76 | P60509 | |
| LEQALQWCQLPEPCS | 1186 | Q8WWN8 | |
| AQWNDSLPTCIVPCG | 1926 | Q7Z407 | |
| ICQPNGQWDKPLPEC | 2976 | Q7Z407 | |
| HELQCQCEEGWIPPD | 641 | Q9UKQ2 | |
| PCNIALCPVDGQWQE | 391 | O60242 | |
| RQQVGECDLPEWCNG | 466 | O43506 | |
| VPDGEWQCPACQPAT | 1221 | Q9UIG0 | |
| QAINRENWCTIEPCP | 1386 | Q12802 | |
| PWDNNAVCADPCSLI | 61 | P24864 | |
| PWIQVCNNFPLLIDC | 211 | P10632 | |
| DGACPTLEQQCQQLW | 516 | Q9BZ11 | |
| CLNGNWTEPPQCKDS | 1091 | P08603 | |
| QPGWQGPLCDQCVTS | 46 | P80370 | |
| QRACNTEPCPPDWVV | 876 | Q9H324 | |
| LETCNPQPCPARWEV | 796 | Q76LX8 | |
| RACNPQECSQPVWVT | 906 | O95450 | |
| QRACNTEPCPPEWFI | 891 | Q9UKP5 | |
| KEPCNNQSCPPQWVA | 951 | Q9UKP5 | |
| CLTPDGQPVQLNETW | 5591 | Q9HC84 | |
| ANPDALQCPIVLCGW | 666 | Q08J23 | |
| ERPGQWACPACTLLN | 411 | O75808 | |
| LNSCPEPSPEVWVCN | 1506 | Q96PE2 | |
| PNAVLLPGCGNWEVC | 616 | M0R2J8 | |
| QCRCLQGEVDCWPLP | 721 | Q99435 | |
| TCAQQLWCPGQPCLP | 841 | Q5IJ48 | |
| QRAGDWKCPNPTCEN | 421 | P35637 | |
| GLILPNGNINWNCPC | 41 | Q8N4Q1 | |
| CQWEPRNQECIALPE | 771 | O75882 | |
| ANFLVWPPCVEVQRC | 116 | P01127 | |
| APNQCQCVPGWRGDD | 116 | Q5VY43 | |
| GWDFQPPLCKDVNEC | 786 | P07202 | |
| GKCLPGPWQCNTVDE | 176 | O75074 | |
| VQGPSCDRCAPNFWN | 1071 | P55268 | |
| NIPPFEGCIWNLVIN | 2676 | P24043 | |
| LPGPWINAACVCAAD | 311 | Q9UPT5 | |
| ELFCQPSGWQLCPER | 46 | O95248 | |
| QTCQQPECASWQAGP | 1101 | Q9P2N4 | |
| EGVVNDELPNCWECP | 706 | Q8NHM5 | |
| WQSPAEPCVLRQCQE | 121 | Q8N8U9 | |
| CDNWNEIGPCNKPCV | 646 | Q8N8U9 | |
| CNIVQQEWGGAIPCQ | 96 | Q96SY0 | |
| CNDSWQGPDCSLNVP | 271 | Q5VV63 | |
| CGWNIKQCEPCSPNV | 366 | P29320 | |
| AAPPQAGCLQLCWEP | 241 | Q99062 | |
| AWQCSDVPEPAVCGI | 521 | Q56NI9 | |
| DNLGQWTAPAPVCQA | 431 | P16109 | |
| WTAPAPVCQALQCQD | 436 | P16109 | |
| QCLATGNWNSVPPEC | 491 | P16109 | |
| GNWNSVPPECQAIPC | 496 | P16109 | |
| QDLWAEICSCLPNPE | 16 | Q9BV29 | |
| DQCENRWTVPATCPQ | 466 | O14682 | |
| AVPDPIPQWNNNACL | 221 | Q8NI29 | |
| DNVQCPKGPDTLWQC | 891 | Q86VB7 | |
| GRPVQVNSDICCPEW | 1516 | Q3ZCN5 | |
| RQWQCDQEPCLVDPD | 131 | Q9GZM7 | |
| IIVQLCDQWDNPAPV | 1281 | A6NHR9 | |
| QCQEVPDCPDPGVWS | 3636 | A2VEC9 | |
| LVDCQVPPGETWQQV | 4921 | A2VEC9 | |
| TQCLLGQPWPLNEAQ | 1296 | Q13428 | |
| CNWFCLDGQPEEVPP | 6 | Q8WZ73 | |
| IPVNCAIPNQDYECW | 16 | Q8WWF3 | |
| NWDAEIPLCKPVNCG | 2936 | Q4LDE5 | |
| QECNILPCPVDGVWS | 831 | Q13591 | |
| WEAPQILNPACRIGC | 341 | O14967 | |
| FLPVNQPEEVWCERC | 526 | Q86XI2 | |
| PLDPQWLVENNITGC | 506 | Q96LI5 | |
| PSSWEGVRCQIPICN | 1541 | Q8N2E2 | |
| VQQGLQTQDWVCEPP | 41 | C9J3V5 | |
| CGNIDPSVLPDNWSC | 271 | Q9H0M4 | |
| LSEWGQILCAICPNP | 3076 | Q8IZQ1 | |
| LCQQEWMCPGPAQRA | 221 | Q9NX65 | |
| CQPCGKEEWAPEGSQ | 536 | Q7RTX1 | |
| WNNLPICQGCLRPLA | 171 | Q5VX71 | |
| EWPSETPVLCQQCGG | 901 | Q9C0C9 | |
| QIWSPGDPCELCICQ | 581 | Q96DN2 | |
| TCLWDPNFQGLCNAP | 141 | O75631 | |
| GVCPNQLSPNLWVDA | 31 | Q96NZ8 | |
| PHEDCPCQQIWEQTA | 86 | Q9UIE0 | |
| CPACQNLQPEWESFA | 56 | Q9H3N1 | |
| VCGQCWRNGQVVEPD | 696 | Q9UGR2 |